Enhanced expression of single immunoglobulin IL-1 receptor-related molecule ameliorates LPS-induced acute lung injury in mice

Shock

Volumn 35, Issue 2, 2011, Pages 198-204

  Chen, Xuxin ^a   Zhao, Yunfeng ^b   Wu, Xueling ^a   Qian, Guisheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

acute lung injury; Acute respiratory distress syndrome; adenoviral vector; LPS; nuclear factor .B; single Ig IL 1 receptorY related receptor; TollYIL 1 receptor 8

Indexed keywords

ADENOVIRUS VECTOR; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; NITRIC OXIDE; RECOMBINANT MURINE SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 RECEPTOR RELATED MOLECULE; RECOMBINANT PROTEIN; SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 RECEPTOR RELATED MOLECULE; TOLL LIKE RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TISSUE LEVEL; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ACUTE LUNG INJURY; ADENOVIRIDAE; ANIMALS; GENE EXPRESSION; HEK293 CELLS; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; RECEPTORS, INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751627946     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181f226f3     Document Type: Article

References (28)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342:1334-1349, 2000.
2. Bi MH, Ott J, Fischer T, Hecker M, Dietrich H, Schaefer MB, Markart P, Wang BE, Seeger W, Mayer K: Induction of lymphocyte apoptosis in a murine model of acute lung injuryVmodulation by lipid emulsions. Shock 33:179-188, 2010.
3. O'Neill LA, Dinarello CA: The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today 21:206-209, 2000.
4. Lissauer ME, Johnson SB, Bochicchio GV, Field CJ, Cross AS, Hasday JD, Whiteford CC, Nussbaumer WA, Towns M, Scalea TM: Differential expression of Toll-like receptor genes: sepsis compared with sterile inflammation 1 day before sepsis diagnosis. Shock 31:238-244, 2009.
5. Martins JO, Ferracini M, Anger DBC, Martins DO, Ribeiro LF Jr, Sannomiya P, Jancar S: Signaling pathways and mediators in LPS-induced lung inflammation in diabetic rats: role of insulin. Shock 33:76-82, 2010.
6. Verstak B, Hertzog P, Mansell A: Toll-like receptor signaling and the clinical benefits that lie within. Inflamm Res 56:1-10, 2007.
7. Liew, FY, Xu D, Brint EK, O'Neill LA: Negative regulation of Toll-like receptorYmediated immune responses. Nat Rev Immunol 5:446-458, 2005.
8. Thomassen E, Renshaw BR, Sims JE: Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11:389-399, 1999.
9. Garlanda C, Riva F, Polentarutti N, Buracchi C, Sironi M, Bortoli MD, Muzio M, Bergottini R, Scanziani E, Vecchi A, et al.: Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci 101:3522-3526, 2004.
10. Polentarutti N, Penton Rol G, Muzio M, Zoja C, Benigni A, Tomasoni S, Vecchi A, Garlanda C, Mantovani A: Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur Cytokine Netw 14:1-8, 2003.
11. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark G.R, Li X: SIGIRR, a negative regulator of Toll-like receptorYinterleukin 1 receptor signaling. Nat Immunol 4:920-927, 2003.
12. Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, et al.: The TollYinterleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26:461-475, 2007.
13. Garlanda C, Riva F, Veliz T, Polentarutti N, Pasqualini F, Radaelli S, Sironi M, Nebuloni M, Omodeo Zorini E, Scanziani E, et al.: Increased susceptibility to colitis-associated cancer of mice lacking Tir8, an inhibitory member of the IL-1 receptor family. Cancer Res 67:6017-6021, 2007.
14. Qin J, Qian Y, Yao J, Grace C, Li X: SIGIRR inhibits interleukin-1 receptor-and Toll-like receptor 4Ymediated signaling through different mechanisms. J Biol Chem 280:25233-25241, 2005.
15. Tian F, Ni YF, Zhao JB, Zhang ZP, Zhang HZ, Liu L, Jiang T, Wang YJ: Single immunoglobulin IL-1 receptorYrelated protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells. Chem Biol Interact 183:442-449, 2010.
16. Zhang C, Wu X, Zhao Y, Deng Z, Qian G: SIGIRR inhibits Toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells. Mol Biol Rep 38:601-609, 2011.
17. Yi C, Wang SR, Zhang SY, Yu SJ, Jiang CX, Zhi MH, Huang Y: Effects of recombinant human growth hormone on acute lung injury in endotoxemic rats. Inflamm Res 55:491-497, 2006.
18. Wu X, Qian G, Zhao Y, Xu D: LBP inhibitory peptide reduces endotoxin-induced macrophage activation and mortality. Inflamm res 54:451-457, 2006.
19. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350, 1984.
20. Huang X, Hazlett LD, Du W, Barrett RP: SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J Immunol 177:548-556, 2006.
21. Takao Y, Mikawa K, Nishina K, Obara H: Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 100:810-816, 2005.
22. Rabinovici R, Neville F, Feuerstein G: Current understanding of sepsis: criticism and a proposal. J Endotoxin Res 2:163-168, 1995.
23. Wei W, Ma B, Li H, Jia Y, Lv K, Wang G, Zhang J, Zhu S, Tang H, Sheng Z, et al.: Biphasic effects of selective inhibition of transforming growth factor "1 activin receptor-like kinase on LPS-induced lung injury. Shock 33:218-224, 2010.
24. Demling RH: The modern version of adult respiratory distress syndrome. N Engl J Med 46:193-202, 1995.
25. Ghatti S, Faggioni R, Echtenacher B, Ghezzi P: Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 91:456-461, 1993.
26. Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P: Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med 123: 394-399, 1994.
27. Abraham E, Kaneko DJ, Shenkar R: Effect of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol Lung Cell Mol Physiol 276:1-8, 1999.
28. Kabir K, Gelinas JP, Chen M, Chen D, Zhang D, Luo X, Yang JH, Carter D, Rabinovici R: Characterization of a murine model of endotoxin-induced acute lung injury. Shock 17:300-303, 2002.